In cancers of non-immune cells, Syk elicits a pro-survival signal, but can also suppress tumourigenesis by restricting epithelial-mesenchymal transition, enhancing cell-cell interactions, and inhibiting migration [13]. The gene discussed is SYK; the disease is cancer.